檢索結果 - Müller, Hannah Deborah

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients

    Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients 由 Suppan, Christoph, Steiner, Daniel, Klocker, Eva Valentina, Posch, Florian, Henzinger, Elisabeth, Müller, Hannah Deborah, Stöger, Herbert, Dandachi, Nadia, Balic, Marija

    出版 2021
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  2. 2
    Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment

    Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment 由 Dandachi, Nadia, Posch, Florian, Graf, Ricarda, Suppan, Christoph, Klocker, Eva Valentina, Müller, Hannah Deborah, Lindenmann, Jörg, Terbuch, Angelika, Heitzer, Ellen, Balic, Marija

    出版 2020
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  3. 3
    Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy

    Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy 由 Müller, Hannah Deborah, Posch, Florian, Suppan, Christoph, Bargfrieder, Ute, Gumpoldsberger, Melanie, Hammer, Robert, Hauser, Hubert, Dandachi, Nadia, Prein, Kurt, Stoeger, Herbert, Lax, Sigurd, Balic, Marija

    出版 2019
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:

檢索工具: